Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Moderna (MRNA)
NASDAQ:MRNA
Holding MRNA?
Track your performance easily
See the Price Targets and Ratings of:
MRNA Analyst Ratings
Hold
4 Buy
11 Hold
4 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MRNA Stock 12 Month Forecast
Average Price Target
$62.31
▲(58.19% Upside)
| Highest Price Target$112.00 | Average Price Target$62.31 | Lowest Price Target$31.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Argus Research
Downgraded
12/17/24
Bank of America Securities
Initiated
12/10/24
Piper Sandler
Reiterated
12/06/24
Leerink Partners
Assigned
12/03/24
J.P. Morgan
Reiterated
11/26/24
RBC Capital
Reiterated
11/25/24
Jefferies
Reiterated
11/21/24
Berenberg Bank
Initiated
11/18/24
Wolfe Research
Initiated
11/14/24
Evercore ISI
Assigned
11/08/24
Goldman Sachs
$130→$112
Buy
184.34%
Upside
Reiterated
11/08/24
Moderna (MRNA) PT Lowered to $112 at Goldman SachsGoldman Sachs analyst Salveen Richter lowered the price target on Moderna (NASDAQ: MRNA) to $112.00 (from $130.00) while maintaining a Buy rating.
Oppenheimer
―
Hold
―
Reiterated
11/08/24
Oppenheimer Sticks to Its Hold Rating for Moderna (MRNA)
Morgan Stanley
$70
Hold
77.71%
Upside
Reiterated
11/08/24
Analysts Conflicted on These Healthcare Names: Moderna (NASDAQ: MRNA), Poseida Therapeutics (NASDAQ: PSTX) and Evolus (NASDAQ: EOLS)
Barclays
$111
Buy
181.80%
Upside
Reiterated
11/08/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (NYSE: CTLT), Moderna (NASDAQ: MRNA) and HCA Healthcare (NYSE: HCA)
Needham
―
Hold
―
Reiterated
11/07/24
Mixed Signals from Moderna's Q3 2024 Performance: Hold Recommendation Issued
Best Analysts Covering Moderna
Which Analyst Should I Follow If I Want to Buy MRNA and Sell After:
1 Month
xxx
Success Rate
23/39 ratings generated profit
Average Return
+0.03%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.97% of your transactions generating a profit, with an average return of +0.03% per trade.
3 Months
xxx
Success Rate
24/39 ratings generated profit
Average Return
-8.46%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of -8.46% per trade.
1 Year
Success Rate
32/39 ratings generated profit
Average Return
-5.53%
assigned a sell rating 18 days ago
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 82.05% of your transactions generating a profit, with an average return of -5.53% per trade.
2 Years
xxx
Success Rate
36/39 ratings generated profit
Average Return
+31.15%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +31.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MRNA Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
7
10
12
10
6
Buy
13
6
4
1
0
Hold
17
19
25
28
19
Sell
2
4
4
7
7
Strong Sell
0
0
0
0
0
total
39
39
45
46
32
Each month's total comprises the sum of three months' worth of ratings.
MRNA Financial Forecast
MRNA Stock Forecast FAQ
What is MRNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Moderna’s 12-month average price target is $62.31.
What is MRNA’s upside potential, based on the analysts’ average price target?
Moderna has 58.19% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MRNA a Buy, Sell or Hold?
Moderna has a consensus rating of Hold which is based on 4 buy ratings, 11 hold ratings and 4 sell ratings.
What is Moderna’s price target?
The average price target for Moderna is $62.31. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $112.00 ,the lowest forecast is $31.00. The average price target represents 58.19% Increase from the current price of $39.39.
The highest analyst price target is $112.00 ,the lowest forecast is $31.00. The average price target represents 58.19% Increase from the current price of $39.39.
What do analysts say about Moderna?
Moderna’s analyst rating consensus is a Hold. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of MRNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.